The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
Identifieur interne : 000271 ( an2020/Analysis ); précédent : 000270; suivant : 000272The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
Auteurs : Giuseppe Lippi [Italie] ; Mario Plebani [Italie]Source :
- Clinical chemistry and laboratory medicine [ 1437-4331 ] ; 2020.
Abstract
Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume the relevance of insidious worldwide threat. One obvious question that is now engaging the minds of many scientists and healthcare professionals is whether and eventually how laboratory medicine could efficiently contribute to counteract this and other (future) viral outbreaks. Despite there being evidence that laboratory tests are vital throughout many clinical pathways, there are at least three major areas where in vitro diagnostics can also provide essential contributions to diagnostic reasoning and managed care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, as well as epidemiologic surveillance. Nonetheless, some structural and practical aspects may generate substantial hurdles in providing timely and efficient response to this infectious emergency, which basically include inadequate (insufficient) environment and shortage of technical and human resources for facing enhanced volume of tests on many infected patients, some of whom are with severe disease. Some proactive and reactive strategies may hence be identified to confront this serious healthcare challenge, which entail major investments on conventional laboratory resources, reinforcement of regional networks of clinical laboratories, installation of mobile laboratories, as well as being proactive in establishing laboratory emergency plans.
DOI: 10.1515/cclm-2020-0240
PubMed: 32191623
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000296
- to stream PubMed, to step Curation: 000296
- to stream PubMed, to step Checkpoint: 000254
- to stream Ncbi, to step Merge: 001306
- to stream Ncbi, to step Curation: 001306
- to stream Ncbi, to step Checkpoint: 001306
- to stream Main, to step Merge: 000273
- to stream Main, to step Curation: 000271
- to stream Main, to step Exploration: 000271
- to stream an2020, to step Extraction: 000271
Links to Exploration step
pubmed:32191623Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.</title><author><name sortKey="Lippi, Giuseppe" sort="Lippi, Giuseppe" uniqKey="Lippi G" first="Giuseppe" last="Lippi">Giuseppe Lippi</name><affiliation wicri:level="1"><nlm:affiliation>Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Plebani, Mario" sort="Plebani, Mario" uniqKey="Plebani M" first="Mario" last="Plebani">Mario Plebani</name><affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Laboratory Medicine, University Hospital of Padova, Padova</wicri:regionArea><wicri:noRegion>Padova</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32191623</idno><idno type="pmid">32191623</idno><idno type="doi">10.1515/cclm-2020-0240</idno><idno type="wicri:Area/PubMed/Corpus">000296</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000296</idno><idno type="wicri:Area/PubMed/Curation">000296</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000296</idno><idno type="wicri:Area/PubMed/Checkpoint">000254</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000254</idno><idno type="wicri:Area/Ncbi/Merge">001306</idno><idno type="wicri:Area/Ncbi/Curation">001306</idno><idno type="wicri:Area/Ncbi/Checkpoint">001306</idno><idno type="wicri:Area/Main/Merge">000273</idno><idno type="wicri:Area/Main/Curation">000271</idno><idno type="wicri:Area/Main/Exploration">000271</idno><idno type="wicri:Area/an2020/Extraction">000271</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.</title><author><name sortKey="Lippi, Giuseppe" sort="Lippi, Giuseppe" uniqKey="Lippi G" first="Giuseppe" last="Lippi">Giuseppe Lippi</name><affiliation wicri:level="1"><nlm:affiliation>Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Plebani, Mario" sort="Plebani, Mario" uniqKey="Plebani M" first="Mario" last="Plebani">Mario Plebani</name><affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Laboratory Medicine, University Hospital of Padova, Padova</wicri:regionArea><wicri:noRegion>Padova</wicri:noRegion></affiliation></author></analytic><series><title level="j">Clinical chemistry and laboratory medicine</title><idno type="eISSN">1437-4331</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume the relevance of insidious worldwide threat. One obvious question that is now engaging the minds of many scientists and healthcare professionals is whether and eventually how laboratory medicine could efficiently contribute to counteract this and other (future) viral outbreaks. Despite there being evidence that laboratory tests are vital throughout many clinical pathways, there are at least three major areas where in vitro diagnostics can also provide essential contributions to diagnostic reasoning and managed care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, as well as epidemiologic surveillance. Nonetheless, some structural and practical aspects may generate substantial hurdles in providing timely and efficient response to this infectious emergency, which basically include inadequate (insufficient) environment and shortage of technical and human resources for facing enhanced volume of tests on many infected patients, some of whom are with severe disease. Some proactive and reactive strategies may hence be identified to confront this serious healthcare challenge, which entail major investments on conventional laboratory resources, reinforcement of regional networks of clinical laboratories, installation of mobile laboratories, as well as being proactive in establishing laboratory emergency plans.</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Lippi, Giuseppe" sort="Lippi, Giuseppe" uniqKey="Lippi G" first="Giuseppe" last="Lippi">Giuseppe Lippi</name></noRegion><name sortKey="Plebani, Mario" sort="Plebani, Mario" uniqKey="Plebani M" first="Mario" last="Plebani">Mario Plebani</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000271 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd -nk 000271 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= an2020
|étape= Analysis
|type= RBID
|clé= pubmed:32191623
|texte= The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/RBID.i -Sk "pubmed:32191623" \
| HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |